Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Structure Therapeutics Inc. - American Depositary Shares (NQ: GPCR ) 45.57 -1.18 (-2.52%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 711,883 Open 46.68 Bid (Size) 45.08 (1) Ask (Size) 46.98 (1) Prev. Close 46.75 Today's Range 44.64 - 46.83 52wk Range 25.57 - 75.02 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Could Structure Therapeutics Become the Next Novo Nordisk? June 17, 2024 Becoming the next Novo Nordisk is a long shot, but it's more likely than it sounds. Via The Motley Fool Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar June 14, 2024 The company just unveiled preclinical results from a test of its GLP-1 weight-loss drug. Via Investor's Business Daily Performance YTD +12.82% +12.82% 1 Month +25.26% +25.26% 3 Month +6.27% +6.27% 6 Month +28.04% +28.04% 1 Year +42.41% +42.41% More News Read More Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy? June 11, 2024 Via The Motley Fool Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet June 10, 2024 Via Investor's Business Daily Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy? June 09, 2024 Via The Motley Fool Top Names Performance Update - Saturday, June 8 June 08, 2024 Via Talk Markets Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million June 08, 2024 Via Talk Markets Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares June 07, 2024 From Structure Therapeutics Inc. Via GlobeNewswire Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering June 05, 2024 From Structure Therapeutics Inc. Via GlobeNewswire The 3 Most Undervalued Biotech Stocks to Buy in June 2024 June 04, 2024 Via InvestorPlace Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants June 03, 2024 From Structure Therapeutics Inc. Via GlobeNewswire Structure Therapeutics' Obesity Candidate Is ' Very Competitive' To Eli Lilly's Orforglipron, Analyst Says June 03, 2024 Via Benzinga Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 03, 2024 Via Benzinga Structure Therapeutics Stock Skyrockets To Six-Month High On Compelling Weight-Loss Drug Results June 03, 2024 Via Investor's Business Daily 10 Health Care Stocks With Whale Alerts In Today's Session June 03, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session June 03, 2024 Via Benzinga Obesity Data From Structure Therapeutics Shows Potential For Weight Loss Drug Candidate June 03, 2024 Via Benzinga Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday June 03, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session June 03, 2024 Via Benzinga Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290 June 03, 2024 From Structure Therapeutics Inc. Via GlobeNewswire Unearthing Unknown Stocks: 3 Picks That Could Be the Next Big Thing May 31, 2024 Via InvestorPlace This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan May 21, 2024 Via Benzinga GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q1 2024 May 09, 2024 Via InvestorPlace Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights May 09, 2024 From Structure Therapeutics Inc. Via GlobeNewswire 7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025 May 09, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.